Ratings by Chardan
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 6/10/2026 | Keay Nakae | CAMP4 Therapeutics Corp | CAMP | New Coverage | Buy (N/A) |
6.50 (N/A) |
4.09 (4.19) |
2.44% | Details |
| 5/11/2026 | Gbola Amusa | Kodiak Sciences Inc. | KOD | Upgrade | Buy (Neutral) |
61.00 (N/A) |
41.01 (34.06) |
-16.95% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 974 more... | |||||||||
